NCT00841113 2009-02-11Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate CancerSpeciality European Pharma LimitedPhase 3 Completed177 enrolled
NCT00100243 2006-09-19Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist TherapyPRAECIS Pharmaceuticals Inc.Phase 2 Completed22 enrolled